I'm a store manager at the spike.
Release time:
2020-08-14
I worked as a store manager in Jianfeng
■ Jianfeng Pharmacy Tong Yanran
I started to contact with the pharmaceutical industry in 2006 . I first worked as a salesperson in a pharmacy that was known as "Jinhua's largest" at that time, starting from a "Xiaobai" who only knew quick and contac, has been constantly learning and job-hopping in the pursuit of self-worth. 2015 6 After I got my license as a licensed pharmacist, I came to the big family of Peak Pharmacy. Thank you very much for the promotion and trust of the leaders, who made me, a new employee, the manager of Donglai Road Pharmacy in 2017 .
I just took over the drugstore. Without any management experience, I faced a series of problems: the transfer of shop assistants, the loss of old customers, the decline of hospital varieties and even the disconnection... What's more serious is that Donglai Road is the most densely populated drugstore in Jinhua City. Our counterparts on the left and right sides are all designated medical insurance stores, but we are not. Obviously, this will greatly reduce our competitiveness. These things add up to something that really bothered me. After the first month's report came out, sales and gross profit fell sharply year-on-year, and the salary that the clerk and I received was also pitifully small. At that time, what made me feel most uncomfortable was not my low income, but the low salary of the shop assistants. I felt very sorry for them. Although they didn't question me too much, I was really lost. I felt that I didn't deserve to be a shop manager. I wanted to give up many times!
Later, with the help of leaders and colleagues, some difficulties were gradually solved, and I gradually sank my heart. As the old saying goes, "when you come, you will be at ease." now that you have taken over the task, roll up your sleeves and work hard!
Although I have no network resources and no management experience, I think I have rich sales experience. As soon as I entered Donglai store, I felt that there were too few large health products in the store, and they were also located relatively far away from the drug area, so I readjusted the display of goods, put them on the side of tonic drugs, and increased the variety, which was more conducive to combined sales. I also teach the shop assistants which drugs can be matched with health care products such as Wei C and Wei B . I also often share some successful sales cases before. They are also willing to learn to use them. The sales volume and gross profit of the stores have gradually improved. Although the sales situation for the whole year was not ideal, the improvement in the fourth quarter and before was obvious, which gives us great confidence in the work of 2018 .
The scale of pharmacies is large and small, the location and surrounding environment are different, and the personality of the clerk is also different. As long as you can choose the right development model that suits you, it is the best. Our drugstore is small in scale, and it is even more necessary to train the clerk to be an "all-round king". The manager should be in a state of striving to be a "model worker", because many things can only be done well if the manager takes the lead. For example, in the POP production competition in a large pharmacy, for the first time I asked the shop assistants to make it. They all pushed it off on the grounds that they could not write well and watched other stores upload pictures one after another. I had to do it myself, unwilling to lag behind. A seemingly simple "June 1" poster, I practiced several times on waste paper before officially making it. I worked hard for almost an afternoon. Although the final effect was not perfect, it was also recognized by the clerk. Therefore, in the second production of POP , they practiced several times on waste paper like me, and finally completed three POP , two of which were independently completed by Chen Shuang, and the other was jointly completed by me and Xiao Teng. Although there is a gap with brother stores, I am most gratified that everyone has participated and paid. I think this is the "model" effect.
Looking back on my more than a year as a store manager, I feel that I have not done well in many aspects, but I firmly believe that at the peak, no matter what kind of job I am in, as long as I am willing to learn and work hard, there will be a day of shining!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page